With the passage of the U.S. Senate's version of the health care reform bill on Christmas Eve, investors may now want to take a look at the growth prospects for the biotech industry. It's likely to benefit from the legislation that's leading to a major health care industry overhaul in 2010. Continue reading S&P's Top Biotech Beneficiaries of Health Care Reform S&P's Top Biotech Beneficiaries of Health Care Reform originally appeared on DailyFinance on Sun, 27 Dec 2009 12:00:00. Filed Under: Investing , Healthcare Permalink | Tweet this! | Comments